Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry

Fig. 2

Kaplan–Meier curves for drug discontinuation and switching. A Comparison of drug discontinuation between b/tsDMARDs in patients with D2T RA. B Comparison of drug switching between b/tsDMARDs in patients with D2T RA. C Comparison of drug discontinuation between b/tsDMARDs in patients without D2T RA. D Comparison of drug switching between b/tsDMARDs in patients without D2T RA

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us